VISN-wide BPA for point of care whole blood glucose testing equipment and supplies
Ended Awarded Last action
- Contract number
- 36C25624N0106
- Awardee
-
Roche Diagnostics Corporation UEI JDMDFEZBYH36
- Awarding agency
-
Veterans Integrated Service Network 16
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $5,174
Award facts
- Contract value 100% obligated
- $5,173.88 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325413 In-Vitro Diagnostic Substance Manufacturing
- Competition
- Full and Open Competition Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Castleton, IN 46256, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Funding Only Action | -$5,713 | |
| Original award | $10,887 |
About this award
Roche Diagnostics Corporation received a Blanket Purchase Agreement (BPA) call award from Veterans Integrated Service Network 16 (VISN 16) on October 1, 2023, for point-of-care whole blood glucose testing equipment and supplies. This contract, valued at $5,173.88 with a firm fixed-price structure, represents a delivery order against the parent In Vitro Diagnostics, Reagents, Test (FSS-65-VII) General Services Administration Schedule contract. The work will be performed in Castleton, Indiana, with an ultimate completion date of September 30, 2024. This award was made without set-aside designation, reflecting open competition in the federal healthcare marketplace.
This procurement supports the Department of Veterans Affairs' diagnostic capabilities across VISN 16, enabling the provision of point-of-care glucose testing solutions to veterans and healthcare facilities within the network. Roche Diagnostics Corporation, a foreign-owned manufacturer headquartered in Indianapolis, maintains an extensive federal contracting presence across multiple Veterans Integrated Service Networks and the Defense Health Agency, supplying comprehensive laboratory equipment and diagnostic technologies. The company's established GSA Schedule vehicle and existing relationships with the VA position it as a primary supplier of advanced diagnostic capabilities to federal healthcare systems, with multiple active indefinite delivery contracts and BPAs extending through 2030.
Quick answers
Who was awarded contract 36C25624N0106?
36C25624N0106 was awarded to Roche Diagnostics Corporation by Veterans Integrated Service Network 16 (Veterans Health Administration) on October 1, 2023.
How much is contract 36C25624N0106 worth?
The government has obligated $5,174 on 36C25624N0106.
Is contract 36C25624N0106 an order under another contract?
Yes. 36C25624N0106 is a BPA call under V797P5279B-36C25621A0023, a blanket purchase agreement, on Invitro Diagnostics, Reagents, Test (FSS-65-VII).
Was contract 36C25624N0106 competed?
The extent of competition for 36C25624N0106 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award